Norway Savings Bank’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $330K | Buy |
+8,598
| New | +$330K | 0.17% | 90 |
|
2023
Q1 | – | Sell |
-1,156
| Closed | -$40.6K | – | 196 |
|
2022
Q4 | $40.6K | Hold |
1,156
| – | – | 0.02% | 193 |
|
2022
Q3 | $34K | Sell |
1,156
-600
| -34% | -$17.6K | 0.02% | 203 |
|
2022
Q2 | $96K | Hold |
1,756
| – | – | 0.05% | 166 |
|
2022
Q1 | $96K | Sell |
1,756
-152
| -8% | -$8.31K | 0.04% | 171 |
|
2021
Q4 | $105K | Sell |
1,908
-1,218
| -39% | -$67K | 0.05% | 168 |
|
2021
Q3 | $149K | Sell |
3,126
-464
| -13% | -$22.1K | 0.07% | 155 |
|
2021
Q2 | $179K | Sell |
3,590
-3,460
| -49% | -$173K | 0.09% | 148 |
|
2021
Q1 | $315K | Sell |
7,050
-312
| -4% | -$13.9K | 0.17% | 113 |
|
2020
Q4 | $339K | Sell |
7,362
-80
| -1% | -$3.68K | 0.19% | 105 |
|
2020
Q3 | $350K | Sell |
7,442
-172
| -2% | -$8.09K | 0.24% | 90 |
|
2020
Q2 | $388K | Buy |
7,614
+2,692
| +55% | +$137K | 0.29% | 80 |
|
2020
Q1 | $233K | Buy |
4,922
+1,820
| +59% | +$86.2K | 0.2% | 97 |
|
2019
Q4 | $182K | Sell |
3,102
-240
| -7% | -$14.1K | 0.13% | 109 |
|
2019
Q3 | $178K | Buy |
3,342
+100
| +3% | +$5.33K | 0.15% | 104 |
|
2019
Q2 | $162K | Hold |
3,242
| – | – | 0.14% | 105 |
|
2019
Q1 | $169K | Sell |
3,242
-64
| -2% | -$3.34K | 0.15% | 104 |
|
2018
Q4 | $158K | Buy |
3,306
+428
| +15% | +$20.5K | 0.15% | 104 |
|
2018
Q3 | $145K | Buy |
2,878
+435
| +18% | +$21.9K | 0.13% | 108 |
|
2018
Q2 | $123K | Buy |
2,443
+739
| +43% | +$37.2K | 0.11% | 115 |
|
2018
Q1 | $83K | Buy |
1,704
+728
| +75% | +$35.5K | 0.08% | 136 |
|
2017
Q4 | $43K | Sell |
976
-1,480
| -60% | -$65.2K | 0.04% | 170 |
|
2017
Q3 | $125K | Sell |
2,456
-160
| -6% | -$8.14K | 0.12% | 116 |
|
2017
Q2 | $141K | Hold |
2,616
| – | – | 0.14% | 113 |
|
2017
Q1 | $138K | Sell |
2,616
-280
| -10% | -$14.8K | 0.14% | 108 |
|
2016
Q4 | $139K | Buy |
+2,896
| New | +$139K | 0.13% | 107 |
|